Search results for "Coronavirus"
Coronavirus
ACP and other health entities are providing information for clinicians as the novel coronavirus disease (COVID-19) continues to spread around the world. ... For these coronavirus education activities, ACP members may report their learning time for CME
March 2020
Preventive care still on during COVID-19
explain the practice's coronavirus-related safety protocols and encourage an in-person visit. ... coronavirus-related safety protocols, or systematically reviewing their panels to flag at-risk patients.
November 2020
Coronavirus
The CDC issued interim guidance for treatment of people potentially exposed to 2019 novel coronavirus (2019-nCoV). ... For these coronavirus education activities, ACP members may report their learning time for CME credit without charge.
February 2020
Latest updates on ACP's priorities, initiatives
Coronavirus: What the Clinician Needs to Know” is a podcast produced by Core IM in collaboration with ACP. ... For these coronavirus education activities, ACP members may report their learning time for CME credit without charge.
March 2020
Coronavirus
By late May, the rate of prescriptions for molnupiravir and nirmatrelvir/ritonavir was twice as high in the highest-income U.S. ZIP codes as in the lowest, research showed. A CDC webinar on June 28 will discuss efforts to equitably distribute these
June 2022
Coronavirus
A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study
April 2022
Coronavirus
The other vaccine used coronavirus-like particles that are produced in plants and display the prefusion spike glycoprotein of the original strain of SARS-CoV-2 combined with an adjuvant.
May 2022
Coronavirus
Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new
January 2022
Coronavirus
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
June 2022
Coronavirus
During the May 24 virtual live event, a panel of experts will discuss challenges related to the care of patients who have lasting symptoms following acute SARS-CoV-2 infection.
May 2022